|
2023
|
Invention
|
Anti-psma single-chain antibody, chimeric antigen receptor associated therewith and use thereof. ... |
|
|
Invention
|
Cd79b humanized antibody-based chimeric antigen receptor and use thereof. Provided are a CD79b hu... |
|
|
Invention
|
Gd2 chimeric antigen receptor and use thereof.
Provided are a disialoganglioside 2 (GD2) chimeri... |
|
|
Invention
|
Gd2 chimeric antigen receptor and use thereof. Provided are a disialoganglioside 2 (GD2) chimeric... |
|
2022
|
Invention
|
Tissue-specific promoter and use thereof.
Provided are a tissue-specific promoter and use thereo... |
|
|
Invention
|
Tissue-specific promoter and use thereof. Provided are a tissue-specific promoter and use thereof... |
|
|
Invention
|
Cd7-based humanized chimeric antigen receptor and use thereof. Provided is a CD7-based humanized ... |
|
|
Invention
|
Recombinant coagulation factor viii and use thereof.
Provided are recombinant coagulation factor... |
|
|
Invention
|
Myeloid-specific promoter and use thereof.
Provided are a myeloid-specific promoter and a use th... |
|
|
Invention
|
Myeloid-specific promoter and use thereof. Provided are a myeloid-specific promoter and a use the... |
|
|
Invention
|
Recombinant coagulation factor viii and use thereof. Provided are recombinant coagulation factor ... |
|
2021
|
Invention
|
Universal sars-cov-2 vaccine and preparation method thereof. A universal SARS-CoV-2 vaccine and a... |
|
|
Invention
|
Cd7-based humanized chimeric antigen receptor and use thereof.
The present application relates t... |
|
2020
|
Invention
|
Cybb lentiviral vector, lentiviral vector-transduced stem cell, and preparation method and applic... |
|
2019
|
Invention
|
Cd19-and cd30-based combined car-t immunotherapy. Provided is an immune cell mixture comprising a... |
|
|
Invention
|
Cd19-and cd70-based combined car-t immunotherapy. It relates to an immune cell mixture comprising... |
|
|
Invention
|
Cd19-and bcma-based combined car-t immunotherapy. Provided is an immune cell mixture comprising a... |
|
|
Invention
|
Cd19-and psma-based combined car-t immunotherapy. Provided is an immune cell mixture comprising a... |
|
|
Invention
|
Cd19-and cd22-based combined car-t immunotherapy. Provided is an immune cell mixture comprising a... |
|
|
Invention
|
Gd2-based chimeric antigen receptor and application thereof. The present application relates to a... |
|
|
Invention
|
Cd19-based chimeric antigen receptor and application thereof. The present application provides a ... |
|
|
Invention
|
A cd19-based chimeric antigen receptor and application thereof. The present application provides ... |
